Cargando…
Vaccines against leishmaniasis: using controlled human infection models to accelerate development
INTRODUCTION: Leishmaniasis is a neglected tropical disease that is defined by the World Health Organization as vaccine preventable. Although several new candidate vaccines are in development, no vaccine has successfully reached the market for human use. Several species of Leishmania cause human dis...
Autores principales: | Parkash, Vivak, Kaye, Paul M., Layton, Alison M, Lacey, Charles J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835556/ https://www.ncbi.nlm.nih.gov/pubmed/34664543 http://dx.doi.org/10.1080/14760584.2021.1991795 |
Ejemplares similares
-
Overcoming roadblocks in the development of vaccines for leishmaniasis
por: Kaye, Paul M., et al.
Publicado: (2021) -
Assessing public perception of a sand fly biting study on the pathway to a controlled human infection model for cutaneous leishmaniasis
por: Parkash, Vivak, et al.
Publicado: (2021) -
A clinical study to optimise a sand fly biting protocol for use in a controlled human infection model of cutaneous leishmaniasis (the FLYBITE study)
por: Parkash, Vivak, et al.
Publicado: (2021) -
Characterization of a new Leishmania major strain for use in a controlled human infection model
por: Ashwin, Helen, et al.
Publicado: (2021) -
Outpatient parenteral antimicrobial therapy for leishmaniasis: 13 years’ experience at a large UK infectious diseases centre
por: Parkash, Vivak, et al.
Publicado: (2023)